Conflicting evidence on the frequency of ESR1 amplification in breast cancer

Research output: Contribution to journalArticle

Abstract

An earlier report of high-frequency ESR1 amplification in breast cancer is now challenged by correspondence from four groups. This discussion of whether or not there is something 'FISHy' about ESR1 amplification highlights the difficulty of validating such observations, leaving the frequency and clinical significance of ESR1 amplification in breast cancer an open question.

Original languageEnglish (US)
Pages (from-to)821-822
Number of pages2
JournalNature Genetics
Volume40
Issue number7
DOIs
StatePublished - Jul 2008

Fingerprint

Breast Neoplasms

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Conflicting evidence on the frequency of ESR1 amplification in breast cancer. / Albertson, Donna.

In: Nature Genetics, Vol. 40, No. 7, 07.2008, p. 821-822.

Research output: Contribution to journalArticle

@article{cf0039bd841345128936b184326e5cfe,
title = "Conflicting evidence on the frequency of ESR1 amplification in breast cancer",
abstract = "An earlier report of high-frequency ESR1 amplification in breast cancer is now challenged by correspondence from four groups. This discussion of whether or not there is something 'FISHy' about ESR1 amplification highlights the difficulty of validating such observations, leaving the frequency and clinical significance of ESR1 amplification in breast cancer an open question.",
author = "Donna Albertson",
year = "2008",
month = "7",
doi = "10.1038/ng0708-821",
language = "English (US)",
volume = "40",
pages = "821--822",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Conflicting evidence on the frequency of ESR1 amplification in breast cancer

AU - Albertson, Donna

PY - 2008/7

Y1 - 2008/7

N2 - An earlier report of high-frequency ESR1 amplification in breast cancer is now challenged by correspondence from four groups. This discussion of whether or not there is something 'FISHy' about ESR1 amplification highlights the difficulty of validating such observations, leaving the frequency and clinical significance of ESR1 amplification in breast cancer an open question.

AB - An earlier report of high-frequency ESR1 amplification in breast cancer is now challenged by correspondence from four groups. This discussion of whether or not there is something 'FISHy' about ESR1 amplification highlights the difficulty of validating such observations, leaving the frequency and clinical significance of ESR1 amplification in breast cancer an open question.

UR - http://www.scopus.com/inward/record.url?scp=46249125768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46249125768&partnerID=8YFLogxK

U2 - 10.1038/ng0708-821

DO - 10.1038/ng0708-821

M3 - Article

VL - 40

SP - 821

EP - 822

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 7

ER -